A New Way to Low: Targeting Residual Inflammatory Risk in ASCVD and CKD

Gain in-depth knowledge on the pivotal role nephrology healthcare professionals have in caring for patients with ASCVD and CKD, including addressing systemic or residual inflammation, through a series of microlearning podcasts, expert written ClinicalThought commentaries, and a text module with accompanying downloadable slides.

Share

Program Content

Activities

Reducing ASCVD Risk in CKD
The Nephrologist’s Role in Targeting ASCVD Risk Reduction in Patients With CKD
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 12, 2024

Expires: June 11, 2025

Faculty

cover img faculity

Mark J. Sarnak, MD, MS

Chief, Division of Nephrology
Tufts Medical Center
Professor of Medicine
Tufts University School of Medicine
Boston, Massachusetts

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in collaboration with American Kidney Fund.

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk

Partners

American Kidney Fund

ProCE Banner